U.S. Markets open in 5 hrs 42 mins

MetLife, Inc. (MET)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
39.67+0.35 (+0.89%)
At close: 4:01PM EDT
Sign in to post a message.
  • B
    Brewster
    Morgan Stanley comments:
    "“We view the announcement today of MetLife’s planned acquisition of Versant health positively. Not only is the transaction consistent with its strategy of growing low capital intensive non-medical health operations, but it also demonstrates management confidence in their current capital position, with the company also announcing plans to complete their existing buyback plan this year, implying roughly $0.5 billion of buybacks by year-end,” said Nigel Dally, equity analyst at Morgan Stanley".
    Bullish
  • B
    Brewster
    METLIFE TO ACQUIRE VERSANT HEALTH, OWNER OF DAVIS VISION AND SUPERIOR VISION
    METLIFE TO ACQUIRE VERSANT HEALTH, OWNER OF DAVIS VISION AND SUPERIOR VISION
    www.businesswire.com
    Neutral
  • B
    Brewster
    From Conference Call held yesterday:
    "As always, we carefully weigh every use of capital against the alternatives. Our goal is to achieve the right balance between investing in growth and returning capital to create long-term shareholder value. With Versant, our confidence could not be higher that we are making the right investment at the right time in the right business.

    As noted in our press release, we are also pleased to announce that we are resuming share repurchases. By the end of the year, we expect to complete the remaining $485 million on our current buyback authorization. Last but not least, we are financing this transaction 100% with cash on our balance sheet.

    As we noted on our Q2 earnings call, we ended the quarter with cash and liquid assets at holding companies of $6.6 billion. Even after the transaction and the completion of our buyback authorization, we still expect to continue to be above our target range. We are moving forward and targeting to close on the Versant acquisition by year-end".
    Bullish
  • g
    gaskm
    I'm in the insurance business, it's hard to by the actual companies. Only UHC/Humana have revenue growth over the next decade. Behmonths like PRU/MET will slowly be zombies.

    Met could be an OKAY stock as long as they increase dividends/buybacks and slash costs.
  • E
    Enzrpaide
    $MET Getting attention. Bullish indication in MACD, Stochastic oscillator and RSI, according to stoxline.
  • S
    Spartacus
    My father’s favor saying was “You send them to school and they eat the books”...That was his way of saying “Be Patient and use Common Sense”,,,Now that I am an AARP member, I can understand...My four over educated children keep giving me get rich advice...Fortunately, I was too ignorant to take their advice and used my own investment philosophy...I sat down and established a retirement budget and invested according to the needs of that budget... I earn an 8% dividend on that budget and all capital gains are rolled over to maintain that cash flow...Thanks MetLife for your dependable Dividend...
  • R
    Rocky
    This is a $50-$55 stock minimum. Bank It !! 💰
  • J
    Jose
    I’m sitting in At 296 shares, I know it’s not allot but it’s enough for me to say that the dividends are GRAVY GOOD! I regret not buying more during the COVID drop. I’m still at green I can sell and make a profit but I plan to keep forever! I have MetLife insurance, they covered 80% of $8500 for medical work for for me and dental work for my 3 kids. I’m happy with them. I’m slowly buying more shares while it’s still cheap.
  • B
    Brewster
    Looks like maybe a 'upgrade' was made (price 'clicking up' at rapid rate!)
  • F
    Fred
    Is the Dividend safe with declining revenue, profit, and investment losses?
  • T
    Thunder7
    MET was $53 pre-Covid. Once everyone realizes that people are not dying more significantly than prior years- then it will go up- a 30% gain from where we are now. Meanwhile collect the dividend from this incredibly solid company.
  • F
    Fred
    BND is a Vanguard Bond fund and way outperforms MET.. Sell MET and buy BND if this an income investment. All the minimal gain from the last 5yrs has been lost and will most likely never come back.. It will take years to get back to what a decent bond fund offers.. MET similar to IBM is a yesteryear investment.
  • Q
    QZB
    If 10 yr. interest rates rose to even 3%, this company would be selling for over 100.
  • R
    Rodd
    On my watch list. Not bad of a market reaction compared to LNC. I prefer ORI over both.
  • S
    Short Bus Driver
    15 years ago, this stock traded at $41 per share. Now it's at $38 per share. Why? Terrible management.
    Don't waste your time on this one.
  • K
    Krakhour
    This company has a lot of money to do things with.....
    Bullish
  • G
    GREG
    this will be 50 by end of year
  • s
    stocktargetadvisor
    $MET
    Target Raised by Morgan Stanley Overweight USD 40 » USD 44
  • m
    moto
    Was thinking of purchasing Met for my IRA, glad I waited but may jump in later this week. Stupid Fed interest policy is killing insurers and other financial related stocks. Eventually the govt. will be the insurer of last resort if interest rate suppression doesn’t end.
  • c
    carol
    this is a 50 dollar stock !